No­vo Hold­ings in­vests in macro­cy­cle start­up Or­bis as once-over­looked mol­e­cules get new in­ter­est

At long last, macro­cy­cles are spin­ning in­to the spot­light.

On Thurs­day, Or­bis Med­i­cines launched with €26 mil­lion in seed fund­ing from Eu­ro­pean VC fund For­bion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER